Integrated ICD-based subtyping and prognostic model reveal KCNN4 as a novel therapeutic target in NSCLC
Abstract Backgrounds Non-small cell lung cancer (NSCLC), the most common type of lung cancer, stands as a leading cause of cancer-related mortality worldwide. Immunogenic cell death (ICD )enhances cancer therapy efficacy by inducing immune responses and reshaping the TIME. While ICD increases cytoto...
Tallennettuna:
| Päätekijät: | , , , , , , , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Springer
2026-02-01
|
| Sarja: | Discover Oncology |
| Aiheet: | |
| Linkit: | https://doi.org/10.1007/s12672-026-04651-8 |
| Tagit: |
Ei tageja, Lisää ensimmäinen tagi!
|
